Sign In
Search Icon
Menu Icon

Intent of Evaluation and Performance Measurement for the Regional Ebola and Other Special Pathogen Treatment Center (RESPTC) FY21 Administrative Supplemental Funding Activities

The $6,000,000 provided through the RESPTC FY21 Administrative Supplement supports the urgent preparedness and response needs of Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs). The Administration for Strategic Preparedness and Response (ASPR) awarded supplemental funding to the 10 recipients of the Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities cooperative agreement (CFDA #93.817) Part B. This cooperative agreement established a nationwide network of regional treatment centers for Ebola and other special pathogen (OSP) care. The funding also enhances preparedness and response capabilities for the RESPTCs to ensure that they are the leading providers of care and treatment for Ebola or OSP patients. RESPTCs determine how to use the supplemental funds concurrent with new activities and those listed in the cooperative agreement.

The purpose of the RESPTC FY21 Administrative Supplemental Funding Performance Measures is to demonstrate the use of funding and the outcomes achieved as a result of this specific funding supplement. The measures will also provide information to identify challenges and successes of activities funded by this supplement. Consistent with the full scope of applicable grant regulations (45 CFR Part 75) and the purpose of this award, the recipients and sub-recipients shall provide ASPR with access to data pertinent to the award in the form of reporting results of the enclosed performance measures.

The remainder of this document describes the performance measures ASPR will use to understand the programmatic effectiveness of the funding distributed through the RESPTC FY21 Administrative Supplement. Where measures require RESPTCs to provide information about ‘ASPR-funded’ activities, the activities include those 1) fully funded by this administrative supplement; 2) partially funded by this administrative supplement and by an RESPTC; and 3) supported by allowable staff positions fully- or partially-funded by these administrative supplements.

All performance measures will be submitted by recipients to HHS ASPR within the data collection period occurring after the end of the performance period. Performance measures will include 1) required quantitative measures to measure funding use and effectiveness, and 2) optional qualitative questions which will identify opportunities, needs, and challenges for RESPTCs, as well as inform future funding opportunities.

Next >>                                      ​​            ​                                                                                                                  << B​ack